A randomised multi centre double blind parallel group trial assessing the analgesic safety and efficacy of GRT9906 in subjects with painful diabetic neuropathy

Trial Profile

A randomised multi centre double blind parallel group trial assessing the analgesic safety and efficacy of GRT9906 in subjects with painful diabetic neuropathy

Suspended
Phase of Trial: Phase II

Latest Information Update: 17 Nov 2010

At a glance

  • Drugs GRT 9906 (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top